Olympus CKX-CCSW software delivers fast, accurate cell counts
for cell culture confluency measurements

11-Dec-2015

CKX-CCSW software automates and simplifies the cell counting process, providing fast and accurate cell counts and consistent confluency measurements

The new Olympus CKX-CCSW confluency check software automatically counts the number of cells and measures cell confluency in a culture vessel, simplifying cell culture workflow and ensuring reliable quality with quantitative cell growth data.

In applications such as stem cell research and regenerative medicine, checking the density of cells growing in a culture vessel is important to monitor the health of cultures. This quantification also allows users to time the transfer of cells to new vessels to prevent overgrowth.

Traditionally, cells are manually counted under a microscope and the results are used to estimate confluency in a process that is both time-intensive and imprecise. Now, CKX-CCSW software automates and simplifies this process, providing fast and accurate cell counts and consistent confluency measurements.

Used with a camera-equipped life science microscope, the software utilises an exclusive Olympus cell-counting algorithm to count cells in a culture vessel accurately, saving time and creating a record of quantifiable cell-growth data that can be used to predict when cells will outgrow the vessel so that they can be subcultured.

CKX-CCSW software counts cells using images obtained with a microscope, so researchers do not have to open the culture vessel or pipette the sample. This reduces the risk of contamination, which can ruin experiments. In addition, as the software works so quickly, cell cultures only need to be removed from the incubator for a short time, minimising culture temperature fluctuations.

Sign up for your free email newsletter

Quantitative data are important both for documentation and accurate prediction of when a cell culture needs to be subcultured; the new software has an intuitive interface so that users can acquire highly accurate, reproducible cell-count data with minimal training. The data can be saved and exported as a CSV file for archiving or further analysis. The count data are easily paired with associated cell culture images for comprehensive recording, simplifying lab processes and analysis.

Featured Companies

Related Content

X-Chem announces achievement of collaboration milestone
X-Chem announces achievement of collaboration milestone
Almirall, Barcelona Supercomputing Center and Nostrum Biodiscovery collaborate to find AI-based therapies
Almirall, Barcelona Supercomputing Center and Nostrum Biodiscovery collaborate to find AI-based therapies
Johnson Matthey partners with Basecamp Research to accelerate the adoption of biocatalysis solutions
Johnson Matthey partners with Basecamp Research to accelerate the adoption of biocatalysis solutions
Scientists harness flower “super power” to pave the way for new drug treatments
Scientists harness flower “super power” to pave the way for new drug treatments
Vilnius University research on bacterial defence from viruses published in Science
Vilnius University research on bacterial defence from viruses published in Science
NIDA funds studies on PN6047 from PharmNovo for potential opioid withdrawal treatment
NIDA funds studies on PN6047 from PharmNovo for potential opioid withdrawal treatment
Bioxodes closes €12 million in Series A funding round
Bioxodes closes €12 million in Series A funding round
Third cancer drug success for Astex drug discovery collaboration
Third cancer drug success for Astex drug discovery collaboration
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement Aimed at Advancing Therapeutic Development
MIMETAS and Yamaha Motor Sign Joint Marketing Agreement Aimed at Advancing Therapeutic Development
Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon
Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon
CN Bio wins "Most Impactful Industry Collaboration of the Year" at the OBN Awards
CN Bio wins "Most Impactful Industry Collaboration of the Year" at the OBN Awards
“Inizio Launch Elevate” set to help global pharma maximise product launch potential
“Inizio Launch Elevate” set to help global pharma maximise product launch potential
Myricx Bio enters into an exclusive antibody license agreement with WuXi Biologics
Myricx Bio enters into an exclusive antibody license agreement with WuXi Biologics
Biotech company awarded prestigious Innovate UK grant to expand search for rare disease therapies
Biotech company awarded prestigious Innovate UK grant to expand search for rare disease therapies
The urgency of cybersecurity: Beamex’s vision for a safer digital future
The urgency of cybersecurity: Beamex’s vision for a safer digital future
CluePoints wins SCRIP award for best contract research organisation (CRO): specialist providers
CluePoints wins SCRIP award for best contract research organisation (CRO): specialist providers